5 Crucial Insights into Low VWF QL: Uncovering a Distinct Cause of Bleeding
Blood Journals Portfolio, an official portfolio of ASH journals, shared a new sudy on X:
”Mild isolated functional VWF defects in the 30 to 50 IU/dL range are common and are associated with significant bleeding in some patients.”
Read the full article here.
The recently published article ‘Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF‘ by Ferdows Atiq et al. in Blood, sheds light on the significant complication risk for people with mild isolated VWF defects.
Emerging data from these combined cohorts in Ireland and Erasmus MC reveal that qualitative low von Willebrand factor (low VWF QL)—characterized by isolated reductions in VWF activity (30–50 IU/dL) despite normal antigen levels—accounts for approximately 50% of patients with low VWF.
Unlike type 2 von Willebrand disease (VWD), low VWF QL represents a distinct clinicopathological entity marked by significant bleeding phenotypes in many affected individuals.
Importantly, these functional defects are primarily driven by impaired VWF biosynthesis in endothelial cells, independent of known genetic variants.
These findings underscore the need for refined diagnostic approaches and tailored management for patients with mild functional VWF defects.

All the latest scientific advancements in the field of bleeding disorders featured in Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
